JANX Q1 2026 Earnings Narrowed Loss Exceeds Expectations as Pipeline Progress Continues ANRO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline CarMax Q1 2026 Earnings EPS Crushes Estimates as Affordability Focus Pays Off Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline CTMX Q1 2026 Earnings Narrower Loss Exceeds Expectations as Pipeline Advances Mercury General MCY Q1 2026 Earnings Massive EPS Surprise on Strong Underwriting Yet Shares Edge Lower